| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Jefferson Cancer Center, Thomas Jefferson University, Philadelphia, Philadelphia 19107
The insulin-like growth factor I receptor (IGF-IR) belongs to the family of transmembrane tyrosine kinase receptors, like the receptors for platelet-derived growth factor, the epidermal growth factor, insulin, and others.
Genetic evidence has shown that the IGF-IR is required for optimal growth in vitro and in vivo. Even more important, however, have been recent findings from several laboratories clearly showing that the IGF-IR is an absolute requirement for the establishment and maintenance of the transformed phenotype, both in vivo and in vitro and in several cell types. These findings indicate that the IGF-IR plays a central role in the mechanism of transformation and, as such, could be a preferred target for therapeutic interventions.
Received 10/21/94. Accepted 11/ 8/94.
This article has been cited by other articles:
![]() |
L. J. Vatten, J. M. Holly, D. Gunnell, and S. Tretli Nested Case-Control Study of the Association of Circulating Levels of Serum Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 with Breast Cancer in Young Women in Norway Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2097 - 2100. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sehat, S. Andersson, L. Girnita, and O. Larsson Identification of c-Cbl as a New Ligase for Insulin-like Growth Factor-I Receptor with Distinct Roles from Mdm2 in Receptor Ubiquitination and Endocytosis Cancer Res., July 15, 2008; 68(14): 5669 - 5677. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Piao, Y. Wang, Y. Adachi, H. Yamamoto, R. Li, A. Imsumran, H. Li, T. Maehata, M. Ii, Y. Arimura, et al. Insulin-like growth factor-I receptor blockade by a specific tyrosine kinase inhibitor for human gastrointestinal carcinomas Mol. Cancer Ther., June 1, 2008; 7(6): 1483 - 1493. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vasilcanu, D. Vasilcanu, B. Sehat, S. Yin, A. Girnita, M. Axelson, and L. Girnita Insulin-Like Growth Factor Type-I Receptor-Dependent Phosphorylation of Extracellular Signal-Regulated Kinase 1/2 but not Akt (Protein Kinase B) Can Be Induced by Picropodophyllin Mol. Pharmacol., March 1, 2008; 73(3): 930 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. de Bono, G. Attard, A. Adjei, M. N. Pollak, P. C. Fong, P. Haluska, L. Roberts, C. Melvin, M. Repollet, D. Chianese, et al. Potential Applications for Circulating Tumor Cells Expressing the Insulin-Like Growth Factor-I Receptor Clin. Cancer Res., June 15, 2007; 13(12): 3611 - 3616. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Girnita, S. K. Shenoy, B. Sehat, R. Vasilcanu, D. Vasilcanu, A. Girnita, R. J. Lefkowitz, and O. Larsson beta-Arrestin and Mdm2 Mediate IGF-1 Receptor-stimulated ERK Activation and Cell Cycle Progression J. Biol. Chem., April 13, 2007; 282(15): 11329 - 11338. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Colon, F. Zaman, M. Axelson, O. Larsson, C. Carlsson-Skwirut, K. V. Svechnikov, and O. Soder Insulin-Like Growth Factor-I Is an Important Antiapoptotic Factor for Rat Leydig Cells during Postnatal Development Endocrinology, January 1, 2007; 148(1): 128 - 139. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Paonessa, D. Foti, V. Costa, E. Chiefari, G. Brunetti, F. Leone, F. Luciano, F. Wu, A. S. Lee, E. Gulletta, et al. Activator Protein-2 Overexpression Accounts for Increased Insulin Receptor Expression in Human Breast Cancer. Cancer Res., May 15, 2006; 66(10): 5085 - 5093. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Martin, N. Melnyk, M. Pollard, M. Bowden, H. Leong, T. J. Podor, M. Gleave, and P. H. B. Sorensen The Insulin-Like Growth Factor I Receptor Is Required for Akt Activation and Suppression of Anoikis in Cells Transformed by the ETV6-NTRK3 Chimeric Tyrosine Kinase. Mol. Cell. Biol., March 1, 2006; 26(5): 1754 - 1769. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Girnita, C. All-Ericsson, M. A. Economou, K. Astrom, M. Axelson, S. Seregard, O. Larsson, and L. Girnita The Insulin-Like Growth Factor-I Receptor Inhibitor Picropodophyllin Causes Tumor Regression and Attenuates Mechanisms Involved in Invasion of Uveal Melanoma Cells Clin. Cancer Res., February 15, 2006; 12(4): 1383 - 1391. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Economou, C. All-Ericsson, V. Bykov, L. Girnita, A. Bartolazzi, O. Larsson, and S. Seregard Receptors for the Liver Synthesized Growth Factors IGF-1 and HGF/SF in Uveal Melanoma: Intercorrelation and Prognostic Implications Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4372 - 4375. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Girnita, S. K. Shenoy, B. Sehat, R. Vasilcanu, A. Girnita, R. J. Lefkowitz, and O. Larsson {beta}-Arrestin Is Crucial for Ubiquitination and Down-regulation of the Insulin-like Growth Factor-1 Receptor by Acting as Adaptor for the MDM2 E3 Ligase J. Biol. Chem., July 1, 2005; 280(26): 24412 - 24419. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Min, Y Adachi, H Yamamoto, A Imsumran, Y Arimura, T Endo, Y Hinoda, C-T Lee, S Nadaf, D P Carbone, et al. Insulin-like growth factor I receptor blockade enhances chemotherapy and radiation responses and inhibits tumour growth in human gastric cancer xenografts Gut, May 1, 2005; 54(5): 591 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Cohen, D. A. Baker, C. Soderstrom, G. Tkalcevic, A. M. Rossi, P. E. Miller, M. W. Tengowski, F. Wang, A. Gualberto, J. S. Beebe, et al. Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti-Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871 Clin. Cancer Res., March 1, 2005; 11(5): 2063 - 2073. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prieur, F. Tirode, P. Cohen, and O. Delattre EWS/FLI-1 Silencing and Gene Profiling of Ewing Cells Reveal Downstream Oncogenic Pathways and a Crucial Role for Repression of Insulin-Like Growth Factor Binding Protein 3 Mol. Cell. Biol., August 15, 2004; 24(16): 7275 - 7283. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Baege, G. L. Disbrow, and R. Schlegel IGFBP-3, a Marker of Cellular Senescence, Is Overexpressed in Human Papillomavirus-Immortalized Cervical Cells and Enhances IGF-1-Induced Mitogenesis J. Virol., June 1, 2004; 78(11): 5720 - 5727. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Hauret, R. M. Bostick, C. E. Matthews, J. R. Hussey, M. F. Fina, K. R. Geisinger, and W. M. Roufail Physical Activity and Reduced Risk of Incident Sporadic Colorectal Adenomas: Observational Support for Mechanisms Involving Energy Balance and Inflammation Modulation Am. J. Epidemiol., May 15, 2004; 159(10): 983 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wessells, S. Yakar, and P. F. Johnson Critical Prosurvival Roles for C/EBP{beta} and Insulin-Like Growth Factor I in Macrophage Tumor Cells Mol. Cell. Biol., April 15, 2004; 24(8): 3238 - 3250. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Girnita, L. Girnita, F. d. Prete, A. Bartolazzi, O. Larsson, and M. Axelson Cyclolignans as Inhibitors of the Insulin-Like Growth Factor-1 Receptor and Malignant Cell Growth Cancer Res., January 1, 2004; 64(1): 236 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bernabei, M. Bosticardo, G. Losana, G. Regis, F. Di Paola, S. De Angelis, M. Giovarelli, and F. Novelli IGF-1 down-regulates IFN-{gamma}R2 chain surface expression and desensitizes IFN-{gamma}/STAT-1 signaling in human T lymphocytes Blood, October 15, 2003; 102(8): 2933 - 2939. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Song, S. C. Cornelius, M. Reiss, and D. Danielpour Insulin-like Growth Factor-I Inhibits Transcriptional Responses of Transforming Growth Factor-{beta} by Phosphatidylinositol 3-Kinase/Akt-dependent Suppression of the Activation of Smad3 but Not Smad2 J. Biol. Chem., October 3, 2003; 278(40): 38342 - 38351. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Min, Y. Adachi, H. Yamamoto, H. Ito, F. Itoh, C.-T. Lee, S. Nadaf, D. P. Carbone, and K. Imai Genetic Blockade of the Insulin-like Growth Factor-I Receptor: A Promising Strategy for Human Pancreatic Cancer Cancer Res., October 1, 2003; 63(19): 6432 - 6441. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Maloney, J. L. McLaughlin, N. E. Dagdigian, L. M. Garrett, K. M. Connors, X.-M. Zhou, W. A. Blattler, T. Chittenden, and R. Singh An Anti-Insulin-like Growth Factor I Receptor Antibody That Is a Potent Inhibitor of Cancer Cell Proliferation Cancer Res., August 15, 2003; 63(16): 5073 - 5083. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wu, K. Cui, K. Miyoshi, L. Hennighausen, J. E. Green, J. Setser, D. LeRoith, and S. Yakar Reduced Circulating Insulin-like Growth Factor I Levels Delay the Onset of Chemically and Genetically Induced Mammary Tumors Cancer Res., August 1, 2003; 63(15): 4384 - 4388. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Girnita, A. Girnita, and O. Larsson Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor PNAS, July 8, 2003; 100(14): 8247 - 8252. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sciacca, M. Prisco, A. Wu, A. Belfiore, R. Vigneri, and R. Baserga Signaling Differences from the A and B Isoforms of the Insulin Receptor (IR) in 32D Cells in the Presence or Absence of IR Substrate-1 Endocrinology, June 1, 2003; 144(6): 2650 - 2658. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Cui, P. Zhang, W. Deng, S. Oesterreich, Y. Lu, G. B. Mills, and A. V. Lee Insulin-Like Growth Factor-I Inhibits Progesterone Receptor Expression in Breast Cancer Cells via the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway: Progesterone Receptor as a Potential Indicator of Growth Factor Activity in Breast Cancer Mol. Endocrinol., April 1, 2003; 17(4): 575 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Labriola, M. Salatino, C. J. Proietti, A. Pecci, O. A. Coso, A. R. Kornblihtt, E. H. Charreau, and P. V. Elizalde Heregulin Induces Transcriptional Activation of the Progesterone Receptor by a Mechanism That Requires Functional ErbB-2 and Mitogen-Activated Protein Kinase Activation in Breast Cancer Cells Mol. Cell. Biol., February 1, 2003; 23(3): 1095 - 1111. [Abstract] [Full Text] |
||||
![]() |
G. Pandini, F. Frasca, R. Mineo, L. Sciacca, R. Vigneri, and A. Belfiore Insulin/Insulin-like Growth Factor I Hybrid Receptors Have Different Biological Characteristics Depending on the Insulin Receptor Isoform Involved J. Biol. Chem., October 11, 2002; 277(42): 39684 - 39695. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Sandhu, D. B. Dunger, and E. L. Giovannucci Insulin, Insulin-Like Growth Factor-I (IGF-I), IGF Binding Proteins, Their Biologic Interactions, and Colorectal Cancer J Natl Cancer Inst, July 3, 2002; 94(13): 972 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sciacchitano, A. Orecchio, L. Lavra, S. Misiti, A. Giacchini, M. Zani, D. Danese, A. Gurtner, S. Soddu, U. Di Mario, et al. Cloning of the Mouse Insulin Receptor Substrate-3 (mIRS-3) Promoter, and Its Regulation by p53 Mol. Endocrinol., July 1, 2002; 16(7): 1577 - 1589. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Khanna, J. Prehn, D. Hayden, R. D. Cassaday, J. Caylor, S. Jacob, S. M. Bose, S.-H. Hong, S. M. Hewitt, and L. J. Helman A Randomized Controlled Trial of Octreotide Pamoate Long-acting Release and Carboplatin versus Carboplatin Alone in Dogs with Naturally Occurring Osteosarcoma: Evaluation of Insulin-like Growth Factor Suppression and Chemotherapy Clin. Cancer Res., July 1, 2002; 8(7): 2406 - 2412. [Abstract] [Full Text] [PDF] |
||||
![]() |
Luis Del Valle, S. Enam, A. Lassak, J. Y. Wang, S. Croul, K. Khalili, and K. Reiss Insulin-like Growth Factor I Receptor Activity in Human Medulloblastomas Clin. Cancer Res., June 1, 2002; 8(6): 1822 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Maile and D. R. Clemmons Regulation of Insulin-like Growth Factor I Receptor Dephosphorylation by SHPS-1 and the Tyrosine Phosphatase SHP-2 J. Biol. Chem., March 8, 2002; 277(11): 8955 - 8960. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. All-Ericsson, L. Girnita, S. Seregard, A. Bartolazzi, M. J. Jager, and O. Larsson Insulin-like Growth Factor-1 Receptor in Uveal Melanoma: A Predictor for Metastatic Disease and a Potential Therapeutic Target Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 1 - 8. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Vella, G. Pandini, L. Sciacca, R. Mineo, R. Vigneri, V. Pezzino, and A. Belfiore A Novel Autocrine Loop Involving IGF-II and the Insulin Receptor Isoform-A Stimulates Growth of Thyroid Cancer J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 245 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Giovannucci Insulin, Insulin-Like Growth Factors and Colon Cancer: A Review of the Evidence J. Nutr., November 1, 2001; 131(11): 3109S - 3120. [Abstract] [Full Text] [PDF] |
||||
![]() |
W Zumkeller IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth? Mol. Pathol., October 1, 2001; 54(5): 285 - 288. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Leng, K. S. Leeding, P. R. Gibson, and L. A. Bach Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo Carcinogenesis, October 1, 2001; 22(10): 1625 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Ly, H T Duc, M Kalamarides, L A Trojan, Y Pan, A Shevelev, J-C Francois, T Noel, A Kane, D Henin, et al. Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma Mol. Pathol., August 1, 2001; 54(4): 230 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nickerson, F. Chang, D. Lorimer, S. P. Smeekens, C. L. Sawyers, and M. Pollak In Vivo Progression of LAPC-9 and LNCaP Prostate Cancer Models to Androgen Independence Is Associated with Increased Expression of Insulin-like Growth Factor I (IGF-I) and IGF-I Receptor (IGF-IR) Cancer Res., August 1, 2001; 61(16): 6276 - 6280. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Andrews, M. Resnicoff, A. E. Flanders, L. Kenyon, M. Curtis, G. Merli, R. Baserga, G. Iliakis, and R. D. Aiken Results of a Pilot Study Involving the Use of an Antisense Oligodeoxynucleotide Directed Against the Insulin-Like Growth Factor Type I Receptor in Malignant Astrocytomas J. Clin. Oncol., April 15, 2001; 19(8): 2189 - 2200. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Khosravi, A. Diamandi, J. Mistry, and A. Scorilas Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein-3 in Benign Prostatic Hyperplasia and Prostate Cancer J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 694 - 699. [Abstract] [Full Text] |
||||
![]() |
S. E. Damon, S. R. Plymate, J. M. Carroll, C. C. Sprenger, C. Dechsukhum, J. L. Ware, and C. T. Roberts Jr. Transcriptional Regulation of Insulin-Like Growth Factor-I Receptor Gene Expression in Prostate Cancer Cells Endocrinology, January 1, 2001; 142(1): 21 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yu and T. Rohan Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression J Natl Cancer Inst, September 20, 2000; 92(18): 1472 - 1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Girnita, A. Girnita, B. Brodin, Y. Xie, G. Nilsson, A. Dricu, J. Lundeberg, J. Wejde, A. Bartolazzi, K. G. Wiman, et al. Increased Expression of Insulin-like Growth Factor I Receptor in Malignant Cells Expressing Aberrant p53: Functional Impact Cancer Res., September 1, 2000; 60(18): 5278 - 5283. [Abstract] [Full Text] |
||||
![]() |
G. von Wichert, P. M. Jehle, A. Hoeflich, S. Koschnick, H. Dralle, E. Wolf, B. Wiedenmann, B. O. Boehm, G. Adler, and T. Seufferlein Insulin-like Growth Factor-I Is an Autocrine Regulator of Chromogranin A Secretion and Growth in Human Neuroendocrine Tumor Cells Cancer Res., August 1, 2000; 60(16): 4573 - 4581. [Abstract] [Full Text] |
||||
![]() |
W. Li, T. Hyun, M. Heller, A. Yam, L. Flechner, J. H. Pierce, and S. Rudikoff Activation of Insulin-like Growth Factor I Receptor Signaling Pathway Is Critical for Mouse Plasma Cell Tumor Growth Cancer Res., July 1, 2000; 60(14): 3909 - 3915. [Abstract] [Full Text] |
||||
![]() |
H. M. Khandwala, I. E. McCutcheon, A. Flyvbjerg, and K. E. Friend The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth Endocr. Rev., June 1, 2000; 21(3): 215 - 244. [Abstract] [Full Text] |
||||
![]() |
E. Giovannucci, M. N. Pollak, E. A. Platz, W. C. Willett, M. J. Stampfer, N. Majeed, G. A. Colditz, F. E. Speizer, and S. E. Hankinson A Prospective Study of Plasma Insulin-like Growth Factor-1 and Binding Protein-3 and Risk of Colorectal Neoplasia in Women Cancer Epidemiol. Biomarkers Prev., April 1, 2000; 9(4): 345 - 349. [Abstract] [Full Text] |
||||
![]() |
J. DiGiovanni, K. Kiguchi, A. Frijhoff, E. Wilker, D. K. Bol, L. Beltran, S. Moats, A. Ramirez, J. Jorcano, and C. Conti Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice PNAS, March 28, 2000; 97(7): 3455 - 3460. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. DiGiovanni, D. K. Bol, E. Wilker, L. Beltrán, S. Carbajal, S. Moats, A. Ramirez, J. Jorcano, and K. Kiguchi Constitutive Expression of Insulin-like Growth Factor-1 in Epidermal Basal Cells of Transgenic Mice Leads to Spontaneous Tumor Promotion Cancer Res., March 1, 2000; 60(6): 1561 - 1570. [Abstract] [Full Text] |
||||
![]() |
A. Vogt, A. S. Wang, C. S. Johnson, J. P. Fabisiak, P. Wipf, and J. S. Lazo In Vivo Antitumor Activity and Induction of Insulin-Like Growth Factor-1-Resistant Apoptosis by SC-alpha alpha delta 9 J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 530 - 537. [Abstract] [Full Text] |
||||
![]() |
K. Nakamura, A. Hongo, J. Kodama, Y. Miyagi, M. Yoshinouchi, and T. Kudo Down-Regulation of the Insulin-like Growth Factor I Receptor by Antisense RNA Can Reverse the Transformed Phenotype of Human Cervical Cancer Cell Lines Cancer Res., February 1, 2000; 60(3): 760 - 765. [Abstract] [Full Text] |
||||
![]() |
A. Misawa, H. Hosoi, A. Arimoto, T. Shikata, S. Akioka, T. Matsumura, P. J. Houghton, and T. Sawada N-Myc Induction Stimulated by Insulin-like Growth Factor I through Mitogen-activated Protein Kinase Signaling Pathway in Human Neuroblastoma Cells Cancer Res., January 1, 2000; 60(1): 64 - 69. [Abstract] [Full Text] |
||||
![]() |
T. Zanocco-Marani, A. Bateman, G. Romano, B. Valentinis, Z.-H. He, and R. Baserga Biological Activities and Signaling Pathways of the Granulin/Epithelin Precursor Cancer Res., October 1, 1999; 59(20): 5331 - 5340. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xie, B. Skytting, G. Nilsson, B. Brodin, and O. Larsson Expression of Insulin-like Growth Factor-1 Receptor in Synovial Sarcoma: Association with an Aggressive Phenotype Cancer Res., August 1, 1999; 59(15): 3588 - 3591. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Schoen, C. M. Tangen, L. H. Kuller, G. L. Burke, M. Cushman, R. P. Tracy, A. Dobs, and P. J. Savage Increased Blood Glucose and Insulin, Body Size, and Incident Colorectal Cancer J Natl Cancer Inst, July 7, 1999; 91(13): 1147 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Swantek and R. Baserga Prolonged Activation of ERK2 by Epidermal Growth Factor and Other Growth Factors Requires a Functional Insulin-Like Growth Factor 1 Receptor Endocrinology, July 1, 1999; 140(7): 3163 - 3169. [Abstract] [Full Text] |
||||
![]() |
T. Nickerson, H. Miyake, M. E. Gleave, and M. Pollak Castration-induced Apoptosis of Androgen-dependent Shionogi Carcinoma Is Associated with Increased Expression of Genes Encoding Insulin-like Growth Factor-binding Proteins Cancer Res., July 1, 1999; 59(14): 3392 - 3395. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pandini, R. Vigneri, A. Costantino, F. Frasca, A. Ippolito, Y. Fujita-Yamaguchi, K. Siddle, I. D. Goldfine, and A. Belfiore Insulin and Insulin-like Growth Factor-I (IGF-I) Receptor Overexpression in Breast Cancers Leads to Insulin/IGF-I Hybrid Receptor Overexpression: Evidence for a Second Mechanism of IGF-I Signaling Clin. Cancer Res., July 1, 1999; 5(7): 1935 - 1944. [Abstract] [Full Text] [PDF] |